Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POTASSIUM ASPARTATE: 86 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
86
Total FAERS Reports
18 (20.9%)
Deaths Reported
49
Hospitalizations
86
As Primary/Secondary Suspect
15
Life-Threatening
12
Disabilities

First Report: 20071114 · Latest Report: 20240811

What Are the Most Common POTASSIUM ASPARTATE Side Effects?

#1 Most Reported
Dyspnoea
22 reports (25.6%)
#2 Most Reported
Atrial fibrillation
22 reports (25.6%)
#3 Most Reported
Nausea
18 reports (20.9%)

All POTASSIUM ASPARTATE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Atrial fibrillation 22 25.6% 0 11
Dyspnoea 22 25.6% 10 10
Delirium 18 20.9% 8 18
Nausea 18 20.9% 8 18
Contusion 16 18.6% 10 16
Drug ineffective 15 17.4% 8 9
Condition aggravated 14 16.3% 9 14
Hypokalaemia 14 16.3% 2 12
Malaise 14 16.3% 8 11
Nasopharyngitis 14 16.3% 2 2
Wheezing 14 16.3% 2 2
Discomfort 13 15.1% 7 13
Muscle spasms 13 15.1% 2 2
Brain natriuretic peptide increased 12 14.0% 0 0
Cardiac disorder 12 14.0% 0 0
Chest discomfort 12 14.0% 0 0
Coronary artery disease 12 14.0% 0 0
Cough 12 14.0% 0 0
Dysphonia 12 14.0% 0 0
Dyspnoea exertional 12 14.0% 0 0

Who Reports POTASSIUM ASPARTATE Side Effects? Age & Gender Data

Gender: 60.2% female, 39.8% male. Average age: 69.4 years. Most reports from: JP. View detailed demographics →

Is POTASSIUM ASPARTATE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2007 1 0 0
2010 2 0 0
2012 1 0 1
2013 3 2 3
2014 2 1 1
2015 7 1 6
2016 7 1 4
2017 3 0 3
2018 18 0 6
2019 6 0 6
2020 2 0 0
2021 4 2 2
2022 4 1 2
2024 2 0 0

View full timeline →

What Is POTASSIUM ASPARTATE Used For?

IndicationReports
Product used for unknown indication 49
Hypokalaemia 16

Official FDA Label for POTASSIUM ASPARTATE

Official prescribing information from the FDA-approved drug label.